Compared to placebo what was the result of inhaled nitric oxide (iNO) on CHI3L1 concentration decline?
The baseline (day 1) CHI3L1 concentration (estimate, 95% CI 213 ng/mL, 176–259) decreased by 34% per day (95% CI 31–38) in the placebo group and 29% per day (95% CI 25–33) in the iNO group (p = 0.007) (Fig. 2).Fig. 2